Literature DB >> 24646614

Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors.

Tatiana Golovko1, Rogier Min2, Natalia Lozovaya3, Caroline Falconer4, Natalia Yatsenko5, Timur Tsintsadze6, Vera Tsintsadze6, Catherine Ledent7, Robert J Harvey8, Delia Belelli4, Jeremy J Lambert4, Andrei Rozov9, Nail Burnashev10.   

Abstract

Cannabinoids are known to regulate inhibitory synaptic transmission via activation of presynaptic G protein-coupled cannabinoid CB1 receptors (CB1Rs). Additionally, recent studies suggest that cannabinoids can also directly interact with recombinant GABAA receptors (GABAARs), potentiating currents activated by micromolar concentrations of γ-aminobutyric acid (GABA). However, the impact of this direct interaction on GABAergic inhibition in central nervous system is unknown. Here we report that currents mediated by recombinant GABAARs activated by high (synaptic) concentrations of GABA as well as GABAergic inhibitory postsynaptic currents (IPSCs) at neocortical fast spiking (FS) interneuron to pyramidal neuron synapses are suppressed by exogenous and endogenous cannabinoids in a CB1R-independent manner. This IPSC suppression may account for disruption of inhibitory control of pyramidal neurons by FS interneurons. At FS interneuron to pyramidal neuron synapses, endocannabinoids induce synaptic low-pass filtering of GABAAR-mediated currents evoked by high-frequency stimulation. The CB1R-independent suppression of inhibition is synapse specific. It does not occur in CB1R containing hippocampal cholecystokinin-positive interneuron to pyramidal neuron synapses. Furthermore, in contrast to synaptic receptors, the activity of extrasynaptic GABAARs in neocortical pyramidal neurons is enhanced by cannabinoids in a CB1R-independent manner. Thus, cannabinoids directly interact differentially with synaptic and extrasynaptic GABAARs, providing a potent novel context-dependent mechanism for regulation of inhibition.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CB1 receptors; DSI; endocannabinoids; fast-spiking interneurons; inhibitory synaptic transmission; neocortex

Mesh:

Substances:

Year:  2014        PMID: 24646614     DOI: 10.1093/cercor/bhu045

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  8 in total

1.  Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones.

Authors:  Adam R Brown; Murray B Herd; Delia Belelli; Jeremy J Lambert
Journal:  J Physiol       Date:  2014-12-03       Impact factor: 5.182

Review 2.  GABAA receptors: structure, function, pharmacology, and related disorders.

Authors:  Amr Ghit; Dina Assal; Ahmed S Al-Shami; Diaa Eldin E Hussein
Journal:  J Genet Eng Biotechnol       Date:  2021-08-21

3.  The GABAA receptor agonist muscimol induces an age- and region-dependent form of long-term depression in the mouse striatum.

Authors:  Xiaoqun Zhang; Ning Yao; Karima Chergui
Journal:  Learn Mem       Date:  2016-08-16       Impact factor: 2.460

4.  A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula.

Authors:  Youngnam Kang; Hajime Sato; Mitsuru Saito; Dong Xu Yin; Sook Kyung Park; Seog Bae Oh; Yong Chul Bae; Hiroki Toyoda
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

5.  Muscarinic Long-Term Enhancement of Tonic and Phasic GABAA Inhibition in Rat CA1 Pyramidal Neurons.

Authors:  Soledad Domínguez; David Fernández de Sevilla; Washington Buño
Journal:  Front Cell Neurosci       Date:  2016-10-26       Impact factor: 5.505

6.  The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.

Authors:  Dan L McElroy; Andrew J Roebuck; Quentin Greba; Sumanta Garai; Asher L Brandt; Orhan Yilmaz; Stuart M Cain; Terrance P Snutch; Ganesh A Thakur; Robert B Laprairie; John G Howland
Journal:  IBRO Neurosci Rep       Date:  2022-01-24

7.  Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin.

Authors:  Alessandra Morano; Pierangelo Cifelli; Paolo Nencini; Letizia Antonilli; Jinane Fattouch; Gabriele Ruffolo; Cristina Roseti; Eleonora Aronica; Cristina Limatola; Carlo Di Bonaventura; Eleonora Palma; Anna Teresa Giallonardo
Journal:  Epilepsia Open       Date:  2016-09-19

Review 8.  Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.

Authors:  Ken Soderstrom; Eman Soliman; Rukiyah Van Dross
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.